Experienced in Familial Isolated Hyperparathyroidism

Dr. Robert Silver

Endocrinology
Center For Community Health At NewYork-Presbyterian Brooklyn Methodist Hospital
515 6th St, 
Brooklyn, NY 
Offers Telehealth

Experienced in Familial Isolated Hyperparathyroidism
Center For Community Health At NewYork-Presbyterian Brooklyn Methodist Hospital
515 6th St, 
Brooklyn, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Silver is an Endocrinologist in Brooklyn, New York. Dr. Silver is rated as an Experienced provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Hyperthyroidism, and Hypothyroidism.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Endocrinology
Licenses
Internal Medicine in NH
Hospital Affiliations
New York-Presbyterian Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
The Wellness Plan Medical Centers
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VNS Health
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Center for Community Health at NewYork-Presbyterian Brooklyn Methodist Hospital
515 6th St, Brooklyn, NY 11215
Call: 347-328-6057

Additional Areas of Focus

Dr. Silver has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: August 24, 2025
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
A Randomized, Phase 3, Open-label Trial Comparing the Effect of the Addition of Tirzepatide Once Weekly Versus Insulin Lispro (U100) Three Times Daily in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin (SURPASS-6)
Enrollment Status: Completed
Publish Date: November 02, 2023
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Lispro, Insulin Glargine
Study Phase: Phase 3
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
A Phase 2, Parallel, Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Insulin-Naïve Patients With Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: November 02, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 1 Diabetes Mellitus Previously Treated With Multiple Daily Injection Therapy
Enrollment Status: Completed
Publish Date: October 27, 2022
Intervention Type: Drug
Study Drugs: LY3209590, Insulin Degludec
Study Phase: Phase 2
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
Randomized, Phase 3, Double-blind Trial Comparing the Effect of the Addition of Tirzepatide Versus Placebo in Patients With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Randomized, Phase 3, Double-blind Trial Comparing the Effect of the Addition of Tirzepatide Versus Placebo in Patients With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without Metformin
Enrollment Status: Completed
Publish Date: January 12, 2022
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
A Phase 2, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog in Adults With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion
Enrollment Status: Completed
Publish Date: January 22, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 7 Less Clinical Trials

2 Total Publications

Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Switching to Once-Weekly Insulin Icodec Versus Once-Daily Insulin Glargine U100 in Type 2 Diabetes Inadequately Controlled on Daily Basal Insulin: A Phase 2 Randomized Controlled Trial.
Journal: Diabetes care
Published: November 25, 2020
View All 2 Publications
Similar Doctors
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Wen T. Shen
General Surgery | Endocrinology
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Wen T. Shen
General Surgery | Endocrinology

New York University

530 1st Ave, 
New York, NY 
 (5.1 miles away)
212-263-7300
Languages Spoken:
English
See accepted insurances

Wen Shen is a General Surgeon and an Endocrinologist in New York, New York. Dr. Shen is rated as a Distinguished provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Familial Isolated Hyperparathyroidism, Parathyroid Hyperplasia, Osteitis Fibrosa, Neonatal Severe Hyperparathyroidism, and Parathyroidectomy.

Distinguished in Familial Isolated Hyperparathyroidism
Dr. Jonas Leibowitz
Endocrinology
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Jonas Leibowitz
Endocrinology

Endocrinology Diabetes And Osteoporosis Consultants LLP

770 McLean Ave Ste B, 
Yonkers, NY 
 (18.4 miles away)
914-650-2806
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonas Leibowitz is an Endocrinologist in Yonkers, New York. Dr. Leibowitz is rated as a Distinguished provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Hashimoto Thyroiditis, Type 2 Diabetes (T2D), Isolated ACTH Deficiency, and Pituitary Apoplexy.

Distinguished in Familial Isolated Hyperparathyroidism
Dr. Chee-yeung Chan
Endocrinology
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Chee-yeung Chan
Endocrinology

Optum Medical Care PC

90 S Bedford Rd, 
Mount Kisco, NY 
 (39.0 miles away)
914-241-1050
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Chee-yeung Chan is an Endocrinologist in Mount Kisco, New York. Dr. Chan is rated as a Distinguished provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Type 2 Diabetes (T2D), and Hashimoto Thyroiditis.

VIEW MORE FAMILIAL ISOLATED HYPERPARATHYROIDISM DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silver's expertise for a condition
ConditionClose
    • Distinguished
    • Type 2 Diabetes (T2D)
      Dr. Silver is
      Distinguished
      . Learn about Type 2 Diabetes (T2D).
      See more Type 2 Diabetes (T2D) experts
    • Advanced
    • Anaplastic Thyroid Cancer
      Dr. Silver is
      Advanced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    • Diabetic Neuropathy
      Dr. Silver is
      Advanced
      . Learn about Diabetic Neuropathy.
      See more Diabetic Neuropathy experts
    • Follicular Thyroid Cancer
      Dr. Silver is
      Advanced
      . Learn about Follicular Thyroid Cancer.
      See more Follicular Thyroid Cancer experts
    • Hyperthyroidism
      Dr. Silver is
      Advanced
      . Learn about Hyperthyroidism.
      See more Hyperthyroidism experts
    • Hypothyroidism
      Dr. Silver is
      Advanced
      . Learn about Hypothyroidism.
      See more Hypothyroidism experts
    • Maturity Onset Diabetes of the Young
      Dr. Silver is
      Advanced
      . Learn about Maturity Onset Diabetes of the Young.
      See more Maturity Onset Diabetes of the Young experts
    View All 12 Advanced Conditions
    • Experienced
    • Adrenal Gland Adenoma
      Dr. Silver is
      Experienced
      . Learn about Adrenal Gland Adenoma.
      See more Adrenal Gland Adenoma experts
    • Adrenal Insufficiency Pediatric
      Dr. Silver is
      Experienced
      . Learn about Adrenal Insufficiency Pediatric.
      See more Adrenal Insufficiency Pediatric experts
    • Diabetic Hyperglycemic Hyperosmolar Syndrome
      Dr. Silver is
      Experienced
      . Learn about Diabetic Hyperglycemic Hyperosmolar Syndrome.
      See more Diabetic Hyperglycemic Hyperosmolar Syndrome experts
    • Diabetic Nephropathy
      Dr. Silver is
      Experienced
      . Learn about Diabetic Nephropathy.
      See more Diabetic Nephropathy experts
    • Eunuchoidism Familial Hypogonadotropic
      Dr. Silver is
      Experienced
      . Learn about Eunuchoidism Familial Hypogonadotropic.
      See more Eunuchoidism Familial Hypogonadotropic experts
    • Familial Hypocalciuric Hypercalcemia Type 1
      Dr. Silver is
      Experienced
      . Learn about Familial Hypocalciuric Hypercalcemia Type 1.
      See more Familial Hypocalciuric Hypercalcemia Type 1 experts
    View All 34 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.